Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Latest revision in the Study Record History is now Revision: v3.5.3, replacing Revision: v3.5.2. This update records a new metadata version for the record rather than altering substantive study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:41:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new UI revision entry, v3.5.2, was added to the Record History and an older revision, v3.5.0, was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:11:27.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T20:23:37.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed in the record history. This appears to be a minor maintenance update to the page history rather than a change to trial details.
    Difference
    0.1%
    Check dated 2026-03-11T20:00:24.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added site revision v3.4.2 and removed the funding-lapse notice and the previous revision v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:34:09.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and updated the page revision to v3.4.1; the previous revision v3.4.0 was removed.
    Difference
    0.9%
    Check dated 2026-02-04T00:22:28.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.